Dynavax Technologies Corporation ($DVAX)
Filing Information
| Accession Number | 0001573072-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 10, 2026 |
| Document Date | Feb 10, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
1,159,978
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President & COO | Common Stock | โ | Feb 10, 2026 | Unknown | 63,334 | โ | โ | 0 | Direct | โ | View Details | |
President & COO | Common Stock - Performance Stock Units | โ | Feb 10, 2026 | Grant/Award | 67,860 | โ | โ | 67,860 | Direct | โ | View Details | |
President & COO | Common Stock - Performance Stock Units | โ | Feb 10, 2026 | Sale to Issuer | 67,860 | โ | โ | 0 | Direct | โ | View Details | |
President & COO | Common Stock - Performance Stock Units | โ | Feb 10, 2026 | Grant/Award | 56,364 | โ | โ | 56,364 | Direct | โ | View Details | |
President & COO | Common Stock - Performance Stock Units | โ | Feb 10, 2026 | Sale to Issuer | 56,364 | โ | โ | 0 | Direct | โ | View Details | |
President & COO | Stock Option (Right to Buy) | Derivative | Feb 10, 2026 | Sale to Issuer | 150,000 | โ | โ | 0 | Direct | โ | View Details | |
President & COO | Stock Option (Right to Buy) | Derivative | Feb 10, 2026 | Sale to Issuer | 150,000 | โ | โ | 0 | Direct | โ | View Details | |
President & COO | Stock Option (Right to Buy) | Derivative | Feb 10, 2026 | Sale to Issuer | 150,000 | โ | โ | 0 | Direct | โ | View Details | |
President & COO | Stock Option (Right to Buy) | Derivative | Feb 10, 2026 | Sale to Issuer | 150,000 | โ | โ | 0 | Direct | โ | View Details | |
President & COO | Stock Option (Right to Buy) | Derivative | Feb 10, 2026 | Sale to Issuer | 95,000 | โ | โ | 0 | Direct | โ | View Details | |
President & COO | Stock Option (Right to Buy) | Derivative | Feb 10, 2026 | Sale to Issuer | 93,000 | โ | โ | 0 | Direct | โ | View Details | |
President & COO | Restricted Stock Units | Derivative | Feb 10, 2026 | Sale to Issuer | 22,620 | โ | โ | 0 | Direct | โ | View Details | |
President & COO | Restricted Stock Units | Derivative | Feb 10, 2026 | Sale to Issuer | 37,576 | โ | โ | 0 | Direct | โ | View Details |